Dapagliflozin R-furanose is a stereospecific degradation impurity of dapagliflozin, characterized by a five-membered furanose ring substituting the native six-membered pyranose moiety. The compound retains the 1,5-dichloro-2,4-dihydroxybenzene core and chlorobenzylidene acetal linkage but exhibits altered glycosidic stereochemistry at the anomeric center. The R-configuration of the furanose ring introduces distinct conformational constraints, differentiating it from S-isomers and other process-related impurities. This species arises via acid-catalyzed retro-aldol fragmentation during stability studies. It functions as an HPLC reference standard for quantifying furanose-specific degradation pathways in dapagliflozin formulations.
On RequestCCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3([C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)Cl
InChI=1S/C21H25ClO7/c1-2-28-15-6-3-12(4-7-15)9-13-10-14(5-8-16(13)22)21(27)20(26)19(25)18(24)17(11-23)29-21/h3-8,10,17-20,23-27H,2,9,11H2,1H3/t17-,18-,19+,20-,21?/m1/s1
KYDGWGYAUCJZDV-AWGDKMGJSA-N